ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream



ProQR Therapeutics N.V. - Ordinary Shares (PRQR): $1.90

0.02 (-1.04%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add PRQR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#147 of 360

in industry

PROQR THERAPEUTICS NV (PRQR) Price Targets From Analysts

Use the tables below to see what analysts covering PROQR THERAPEUTICS NV think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-28 6 $33 $18 $22.75 $2.01 1031.84%
2022-01-31 5 $33 $18 $22 $2.01 994.53%
2022-02-14 6 $18 $1.7 $6.74 $2.01 235.32%
2022-02-28 6 $8 $1.7 $4.74 $2.01 135.82%
2022-04-17 5 $4 $1.7 $2.8 $2.01 39.3%
2022-04-19 5 $4 $1.7 $2.94 $2.01 46.27%
2022-05-09 6 $2.5 $1 $1.8 $2.01 -10.45%
2022-08-06 6 $3.5 $1 $2.04 $2.01 1.49%
2022-08-15 7 $3.5 $1 $1.95 $2.01 -2.99%
2022-11-10 7 $2 $0.8 $1.4 $2.01 -30.35%
2022-12-23 6 $5 $1 $2.84 $2.01 41.29%
2023-05-17 6 $6 $2 $4.6 $2.01 128.86%
2023-08-07 6 $6 $2 $4.5 $2.01 123.88%
2023-09-18 6 $6 $1.8 $4.05 $2.01 101.49%
2023-11-08 6 $6 $1.8 $3.76 $2.01 87.06%
2023-11-10 7 $6 $1.8 $3.76 $2.01 87.06%

The Trend in the Analyst Price Target


Over the past 27 months, PRQR's average price target has gone down $21.75.

PRQR reports an average of 181.22% for its upside potential over the past 32 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-30 6 6 2.0 4.600 1.99 131.16%
2023-09-18 6 6 1.8 4.050 1.54 162.99%
2023-11-08 7 6 1.8 4.200 1.35 211.11%
2023-11-08 7 6 1.8 3.883 1.35 187.63%
2023-11-08 6 6 1.8 3.760 1.35 178.52%

PRQR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 5 1 1 0 0 7

The Trend in the Broker Recommendations


Over the past 26 weeks, PRQR's average broker recommendation rating improved by 0.4.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRQR as an investment opportunity.

  • In the context of all US stocks, PROQR THERAPEUTICS NV's average analyst price target is greater than 141.33% of them.
  • In terms of how PROQR THERAPEUTICS NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2362.61% of that group.
  • In terms of how PROQR THERAPEUTICS NV fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1950.76% of that group.
  • In terms of how PROQR THERAPEUTICS NV fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1359.45% of that group.

Stocks similar to PROQR THERAPEUTICS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AFMD, SMMT, and KALV.

Is PRQR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!